← back to search

Lyn M. Duncan

Harvard University · US
Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, Immunotherapy and Immune Responses, and Cancer Genomics and Diagnostics.
h-index
30
citations
6,798
works
68
NIH funding
primary concept
email

Recent publications

<scp>WHO</scp> classification of skin tumours: key updates in the fifth edition
Histopathology 2025cited by 4position: middledoi
Revision of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis Classification Schema for Melanocytic Lesions
JAMA Network Open 2023cited by 63position: middledoi
Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway
Blood 2021cited by 30position: middledoi
Appropriate use criteria for ancillary diagnostic testing in dermatopathology: New recommendations for 11 tests and 220 clinical scenarios from the American Society of Dermatopathology Appropriate Use Criteria Committee
Journal of Cutaneous Pathology 2021cited by 16position: middledoi
Biomarkers for Melanoma
2020cited by 1position: middledoi
BRCA1‐associated protein (BAP1)‐inactivated melanocytic tumors
Journal of Cutaneous Pathology 2019cited by 57position: lastdoi
Biomarkers for Melanoma
2019cited by 0position: middledoi
Resistance to checkpoint blockade therapy through inactivation of antigen presentation
Nature Communications 2017cited by 992position: middledoi
Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group
Journal of the American Academy of Dermatology 2016cited by 37position: middledoi
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
Cell 2012cited by 802position: middledoi
Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families
PLoS ONE 2012cited by 253position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Selma Ugurel · Kliniken Essen-Mitte2 papers (2019–2020)Mohammed Kashani–Sabet · California Pacific Medical Center2 papers (2019–2020)Hensin Tsao · MGH Institute of Health Professions2 papers (2012–2019)Keith T. Flaherty · Boston Medical Center2 papers (2019–2020)Dirk Schadendorf · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori2 papers (2019–2020)Margaret M. DeAngelis · University of Utah1 papers (2012–2012)Gary S. Wood · University of Wisconsin Carbone Cancer Center1 papers (2021–2021) · 1 papers (2012–2012)Pedram Gerami · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2016–2016)Michael S. Khodadoust · Stanford Medicine1 papers (2021–2021) · 1 papers (2016–2016)Emily Y. Chu · Palo Alto University1 papers (2016–2016)Michael Taylor · Lund University1 papers (2012–2012) · 1 papers (2016–2016)Birgitta Schmidt · Boston Children's Hospital1 papers (2016–2016)Valentina Nardi · Biopredic (France)1 papers (2021–2021)Joan Guitart · Northwestern Memorial Hospital1 papers (2021–2021)Caroline Snowden · Northwestern University1 papers (2021–2021)Lori Lowe · University of Michigan–Ann Arbor1 papers (2016–2016)Joost J. van den Oord · KU Leuven1 papers (2016–2016)